BGLC vs RF
BioNexus Gene Lab Corp Common stock (BGLC) versus RF (RF) — a side-by-side from cached financials, not a winner call.
BioNexus Gene Lab Corp Common stock (BGLC) is a specialty chemicals company listed on NASDAQ.
RF (RF) common stock.
Latest reported BGLC revenue for 2024-12-31 was $9.5M. Net income was $1.6M. Revenue was down 2.7% from 2023-12-31 to 2024-12-31. BGLC currently screens at market cap $6.1M.
RF does not have a complete income-statement cache yet.
BGLC currently screens at market cap $6.1M. RF currently screens at market cap $0.
Not investment advice. Open the BGLC and RF stock pages for the full models.
Not investment advice.